Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Roumen Balabanov"'
Autor:
Jai Perumal, Roumen Balabanov, Laura Balcer, Steven Galetta, Zhaonan Sun, Hanyue Li, Danette Rutledge, Robin L. Avila, Robert J. Fox
Publikováno v:
Neurology and Therapy, Vol 12, Iss 3, Pp 833-848 (2023)
Abstract Introduction In STRIVE, natalizumab treatment demonstrated effectiveness in clinical, magnetic resonance imaging (MRI), and patient-reported outcomes (PROs) in patients with early relapsing–remitting multiple sclerosis (RRMS). This post ho
Externí odkaz:
https://doaj.org/article/5c821f4c41a3497980c7a8b0b691e1de
Autor:
Roumen Balabanov
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 17 (2023)
Externí odkaz:
https://doaj.org/article/d8c069821f5e4379bd4fc8b4a72ab8ef
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundAutoimmune diseases can coexist with immunodeficiency. We describe a treatment approach in which granulocyte-colony stimulating factor (G-CSF) is used to restore immune competence without worsening autoimmunity. G-CSF is a polyfunctional cy
Externí odkaz:
https://doaj.org/article/881a5ea497f34d69807717de07f99356
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 'long haulers'
Autor:
Edith L. Graham, Jeffrey R. Clark, Zachary S. Orban, Patrick H. Lim, April L. Szymanski, Carolyn Taylor, Rebecca M. DiBiase, Dan Tong Jia, Roumen Balabanov, Sam U. Ho, Ayush Batra, Eric M. Liotta, Igor J. Koralnik
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 8, Iss 5, Pp 1073-1085 (2021)
Abstract Objective Most SARS‐CoV‐2‐infected individuals never require hospitalization. However, some develop prolonged symptoms. We sought to characterize the spectrum of neurologic manifestations in non‐hospitalized Covid‐19 “long hauler
Externí odkaz:
https://doaj.org/article/bf746237121e45d59790e5bc48dc6724
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Neuromyelitis optica (NMO) is a chronic inflammatory disease of the central nervous system that primarily affects the optic nerves and spinal cord of patients, and in some instances their brainstem, diencephalon or cerebrum as spectrum disorders (NMO
Externí odkaz:
https://doaj.org/article/b207d5385ef64ba6a3b3bc818daeb589
Autor:
Jai Perumal, Robert J. Fox, Roumen Balabanov, Laura J. Balcer, Steven Galetta, Shavy Makh, Sourav Santra, Christophe Hotermans, Lily Lee
Publikováno v:
BMC Neurology, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background STRIVE is a multicenter, observational, open-label, single-arm study of natalizumab in anti–JC virus (JCV) seronegative patients with early relapsing-remitting multiple sclerosis (RRMS). The objective of this prespecified 2-year
Externí odkaz:
https://doaj.org/article/0a6e2137e27b4e0ea304899ccd3fcf9a
Autor:
Dusan Stefoski, Roumen Balabanov, Rasha Waheed, Michael Ko, Igor J. Koralnik, Fabian Sierra Morales
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 6, Iss 5, Pp 923-931 (2019)
Abstract Objective There is no consensus on the treatment of progressive multifocal leukoencephalopathy (PML) occurring in multiple sclerosis (MS) patients treated with natalizumab (Nz). We report novel immune activating treatment with filgrastim of
Externí odkaz:
https://doaj.org/article/76bc9ab5e05d4e8584ffb602e9c65c84
Autor:
Richard K. Burt, Paul Tappenden, Roumen Balabanov, Xiaoqiang Han, Kathleen Quigley, John A. Snowden, Basil Sharrack
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background: Intravenous immunoglobulin (IVIG) is effective as standard first line therapy for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), but some patients remain dependent on its long-term use. Recently, we have reported that a
Externí odkaz:
https://doaj.org/article/07eb9f1b2a194530ae78ae77c0ee2735
Autor:
Haley E. Titus, Yanan Chen, Joseph R. Podojil, Andrew P. Robinson, Roumen Balabanov, Brian Popko, Stephen D. Miller
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 14 (2020)
Multiple Sclerosis (MS) is an immune-mediated neurological disorder, characterized by central nervous system (CNS) inflammation, oligodendrocyte loss, demyelination, and axonal degeneration. Although autoimmunity, inflammatory demyelination and neuro
Externí odkaz:
https://doaj.org/article/1ab37b89f5234467a7b645562874cd52
Autor:
Benjamin Bienia, Roumen Balabanov
Publikováno v:
Autoimmune Diseases, Vol 2013 (2013)
Neuromyelitis optica (NMO) is a chronic inflammatory disease of the central nervous system that affects the optic nerves and spinal cord resulting in visual impairment and myelopathy. There is a growing body of evidence that immunotherapeutic agents
Externí odkaz:
https://doaj.org/article/dba4a902f98548db9291672f5b78ee0b